VZN:SIXVZ Holding AG Analysis
Data as of 2026-07-01 - not real-time
CHF 153.00
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
VZ Holding AG is trading at CHF 153, just shy of the identified resistance around CHF 153.4 and comfortably above the 20‑day and 50‑day SMAs (CHF 148.4 and CHF 148.7). The MACD shows a bullish signal while the RSI sits at 62, hinting at strong upward momentum but also edging into overbought territory. Volume is on an increasing trend, and the stock’s beta of roughly 0.1 signals very low market sensitivity, though 30‑day volatility of about 16½% adds a modest price swing risk.
Fundamentally, the company delivers solid top‑line growth of 7 % YoY, with gross margins above 64 % and operating margins near 46 %. Cash reserves dwarf debt, and a payout ratio under 50 % supports the current 1.95 % dividend. A discounted cash‑flow model places fair value near CHF 447, implying a sizable upside to the consensus target of CHF 183 and an overall undervaluation relative to the market price.
Fundamentally, the company delivers solid top‑line growth of 7 % YoY, with gross margins above 64 % and operating margins near 46 %. Cash reserves dwarf debt, and a payout ratio under 50 % supports the current 1.95 % dividend. A discounted cash‑flow model places fair value near CHF 447, implying a sizable upside to the consensus target of CHF 183 and an overall undervaluation relative to the market price.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish trend direction despite bullish MACD
- RSI approaching overbought levels
- Price near short‑term resistance
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF‑derived fair value far above current price
- Strong profit and operating margins
- Sustainable dividend with healthy cash flow
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Low beta indicating defensive profile
- Robust balance sheet with ample cash versus debt
- Long‑term upside potential reflected in analyst target and valuation gap
Key Metrics & Analysis
Financial Health
Revenue Growth7.10%
Profit Margin37.62%
P/E Ratio25.7
ROE21.07%
ROA2.25%
Debt/Equity60.89
P/B Ratio5.1
Op. Cash FlowCHF215.0M
Free Cash FlowCHF896.3M
Industry P/E16.9
Technical Analysis
TrendBearish
RSI62.3
SupportCHF 141.20
ResistanceCHF 153.40
MA 20CHF 148.44
MA 50CHF 148.73
MA 200CHF 152.60
MACDBullish
VolumeIncreasing
Fear & Greed Index91.23
Valuation
Fair ValueCHF 446.73
Target PriceCHF 183.00
Upside/Downside19.61%
GradeUndervalued
TypeGrowth
Dividend Yield1.95%
Risk Assessment
Beta0.11
Volatility16.57%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.